Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Eye Tech Care of France Reports $27 Million Funding from China

publication date: Jan 12, 2016
Eye Tech Care SA, a medical device maker located in Lyon, France, received a cross-border $27 million funding from China's Everpine Capital to support development of Eye Tech Care's non-invasive ultrasound treatment for glaucoma, particularly in China. EyeOP1®, an innovative medical device that uses Ultrasound Ciliary Plasty, treats uncontrolled glaucoma regardless of previous treatment. Eye Tech Care began the China registration process for EyeOPI in 2015. Everpine invests in companies that want to expand into China. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital